Emergency physicians first to safely treat vaccine-induced blood clot with heparin alternative

WASHINGTON, DC — A new case report, detailed in Annals of Emergency Medicine , is the first known case of a patient with VITT (vaccine-induced thrombotic thrombocytopenia) treated with a heparin alternative following the Centers for Disease Control and Prevention…

ACS Spring 2021 press conference schedule

Watch live and recorded press conferences at http://www. acs. org/ acsspring2021conferences . Press conferences will be held Monday, April 5, through Friday, April 16, 2021. Below is the schedule, which will be updated as needed. ALL TOPICS ARE STRICTLY EMBARGOED…

CHOP-led Research Study Identifies Key Target in Treatment-Resistant Hemophilia A

Researchers at Children’s Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in about 30% of patients with hemophilia A. The target, known as B cell activating factor (BAFF), appears to promote antibodies against and inhibitors of the missing blood clotting factor that is given to these patients to control their bleeding episodes. The findings, published in the Journal of Clinical Investigation, raise the possibility of using anti-BAFF therapies, potentially in combination with immune tolerance therapies, to tame the immune response in some patients with severe hemophilia A.

FDA approvals strengthen Octapharma USA pediatric critical care product portfolio

Octaplas™ and fibryga® receive new product labeling following FDA’s approval of BLA supplements to update therapy research; FDA expands fibryga® indication to include treatment of children under 12 years of age

Outpatient management following diagnosis of acute pulmonary embolism

Despite guidelines promoting outpatient management of patients with low-risk pulmonary embolism (PE), few patients are currently discharged home from hospital emergency departments in the United States. That is the conclusion of a study titled Outpatient Management of Patients Following Diagnosis…

Discovery of new protein with an important role in atherosclerosis

Atherosclerosis is the underlying condition that causes heart attacks and strokes. Researchers at Radboudumc in the Netherlands have discovered a protein that appears to play an important role in atherosclerosis. The protein is called Prosaposin, and its role in atherosclerosis…

Biomarkers that could help determine who’s at risk for severe COVID-19 symptoms

One of the many mysteries still surrounding COVID-19 is why some people experience only mild, flu-like symptoms, whereas others suffer life-threatening respiratory problems, vascular dysfunction and tissue damage. Now, researchers reporting in ACS’ Analytical Chemistry have used a combination of…

Researchers develop 10-minute COVID-19 diagnostic test that wage workers can afford

Technology based on nanoparticles identifies IgG antibodies and costs only about a fifth of similar devices now on the market. It was developed by scientists at the University of São Paulo and Brazilian startup Biolinker.

Assessment of maternal, neonatal cord blood SARS-CoV-2 antibodies, placental transfer ratios

What The Study Did: Maternally derived antibodies are a key element of neonatal immunity. This study examined the association between maternal and neonatal SARS-CoV-2-specific antibody concentrations because understanding the dynamics of maternal antibody responses to SARS-CoV-2 infection during pregnancy and subsequent…